CVS Health Corporation $CVS Shares Sold by Exencial Wealth Advisors LLC

Exencial Wealth Advisors LLC trimmed its holdings in CVS Health Corporation (NYSE:CVS) by 3.9% in the second quarter, Holdings Channel.com reports. The institutional investor owned 43,062 shares of the pharmacy operator’s stock after selling 1,742 shares during the quarter. Exencial Wealth Advisors LLC’s holdings in CVS Health were worth $2,970,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the business. Hazlett Burt & Watson Inc. raised its position in shares of CVS Health by 10.9% in the second quarter. Hazlett Burt & Watson Inc. now owns 1,682 shares of the pharmacy operator’s stock valued at $117,000 after buying an additional 165 shares during the last quarter. Essex Financial Services Inc. increased its position in CVS Health by 0.8% during the first quarter. Essex Financial Services Inc. now owns 20,705 shares of the pharmacy operator’s stock worth $1,403,000 after purchasing an additional 166 shares during the last quarter. Williams Financial LLC increased its position in CVS Health by 2.5% during the second quarter. Williams Financial LLC now owns 6,923 shares of the pharmacy operator’s stock worth $478,000 after purchasing an additional 167 shares during the last quarter. Hemington Wealth Management increased its position in CVS Health by 33.7% during the first quarter. Hemington Wealth Management now owns 682 shares of the pharmacy operator’s stock worth $46,000 after purchasing an additional 172 shares during the last quarter. Finally, Sumitomo Life Insurance Co. increased its position in CVS Health by 1.0% during the first quarter. Sumitomo Life Insurance Co. now owns 17,114 shares of the pharmacy operator’s stock worth $1,159,000 after purchasing an additional 174 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Trading Down 1.2%

Shares of CVS stock opened at $82.08 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. The firm has a market cap of $104.11 billion, a PE ratio of 22.93, a price-to-earnings-growth ratio of 0.92 and a beta of 0.60. The company has a 50-day moving average of $75.02 and a two-hundred day moving average of $68.45. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $83.52.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, beating the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The business had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. During the same quarter last year, the firm posted $1.83 earnings per share. The business’s revenue for the quarter was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be paid a $0.665 dividend. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.2%. CVS Health’s dividend payout ratio (DPR) is presently 74.30%.

Insider Activity at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the transaction, the director owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 1.22% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently issued reports on CVS. Bernstein Bank cut their price objective on shares of CVS Health from $78.00 to $72.00 and set a “market perform” rating for the company in a research report on Wednesday, July 16th. Cantor Fitzgerald restated an “overweight” rating and set a $78.00 price objective on shares of CVS Health in a research report on Tuesday, August 26th. Jefferies Financial Group raised their price objective on shares of CVS Health from $80.00 to $92.00 in a research report on Wednesday, October 15th. Sanford C. Bernstein raised their price objective on shares of CVS Health from $72.00 to $77.00 and gave the stock a “market perform” rating in a research report on Friday, September 5th. Finally, UBS Group upgraded shares of CVS Health from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $67.00 to $79.00 in a research report on Monday, August 18th. Two research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, CVS Health has a consensus rating of “Moderate Buy” and an average price target of $82.57.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.